Cytokine Release Syndrome
CRS is an acute systemic inflammatory response characterized by fever and multiple organ dysfunction associated with CAR T-cell therapy, therapeutic antibodies, haploidentical allogeneic transplantation, etc. Immune effector cell-associated neurotoxicity syndrome (ICANS) is a neuropsychiatric syndrome that can occur in some patients treated with immunotherapy and may or may not accompany CRS.
&nbsp;
Cytokine Release Syndrome Epidemiology Segmentation in the 7MM
<ul>
<li class="ql-align-justify">Total Incident Cases of CRS</li>
<li class="ql-align-justify">Grade-specific Cases of CRS</li>
<li class="ql-align-justify">CRS cases by CAR-T Therapies</li>
<li class="ql-align-justify">CRS cases by Bispecific Antibodies</li>
<li class="ql-align-justify">CRS cases by Allogenic Transplant</li>
</ul>
&nbsp;
<a style="color: black;" href="https://www.delveinsight.com/report-store/cytokine-release-syndrome-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Cytokine Release Syndrome Epidemiological Insights Observed in the 7MM (2021)</a>
<ul>
<li class="ql-align-justify">The total number of incident cases of Cytokine Release Syndrome observed in the 7MM was observed to be 48,853 cases in the year 2021</li>
</ul>
&nbsp;
<a style="color: black;" href="https://www.delveinsight.com/report-store/cytokine-release-syndrome-market" target="_blank" rel="noopener noreferrer">Cytokine Release Syndrome Market Insight</a>
The market size of Cytokine Release Syndrome in the 7MM was found to be approximately ~USD 4 million in 2021
&nbsp;
Cytokine Release Syndrome Market Strengths
Increase in the acceptance for immunotherapy for the treatment of solid tumours acts as the vital factor escalating the market growth.&nbsp;
&nbsp;
Cytokine Release Syndrome Market Opportunities
Single approved therapy in the market, so there is an opportunity for developing companies to capture the market with their assets.
&nbsp;
<a style="color: black;" href="https://www.delveinsight.com/report-store/cytokine-release-syndrome-pipeline-insight" target="_blank" rel="noopener noreferrer">Cytokine Release Syndrome Emerging Drugs and Key Companies</a>
<ul>
<li>Itacitinib: (Incyte Corporation)</li>
<li>KINERET (anakinra): Swedish Orphan Biovitrum (sobi)</li>
</ul>

Cytokine Release Syndrome (CRS) Market

Cytokine Release Syndrome (CRS) Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.